omeprazole and diazepam

omeprazole has been researched along with diazepam in 42 studies

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-19904 (9.52)18.7374
1990's14 (33.33)18.2507
2000's13 (30.95)29.6817
2010's10 (23.81)24.3611
2020's1 (2.38)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Flouvat, B; Karolac-Tamisier, S; Lefebvre, RA; Moerman, E; Van Ganse, E1
Humphries, TJ1
Andersson, T; Cederberg, C; Edvardsson, G; Heggelund, A; Lundborg, P1
Brand, U; Gönne, S; Hanauer, G; Kromer, W; Parsons, ME; Postius, S; Riedel, R; Simon, WA1
Andersson, T; Andrén, K; Cederberg, C; Edvardsson, G; Heggelund, A; Lundborg, P1
Ayrton, A; Chenery, RJ; Norman, SJ; Oldham, HG; Standring, P1
Regårdh, CG1
Gugler, R; Jensen, JC2
Caraco, Y; Tateishi, T; Wood, AJ1
Chiba, K; Hayashi, M; Horai, Y; Ishizaki, T; Koyama, E; Manabe, K; Tomono, Y; Toyoki, T; Yamato, C; Yasuda, S1
Bliesath, H; Hartmann, M; Huber, R; Radtke, HW; Steinijans, VW; Wurst, W; Zech, K1
Bertilsson, L1
Houston, JB; Zomorodi, K3
Bliesath, H; Brod, I; Gugler, R; Hartmann, M; Huber, R; Klotz, U; Rudi, J; Steinijans, VW; Wurst, W1
Fask, A; Saltiel, E1
Adler, ID; Baumgartner, A; Schmid, TE1
Sontag, SJ1
Bertino, JS; Nafziger, AN; Rogers, JF1
Hallifax, D; Houston, JB; Jones, HM1
Chang, SY; Chen, C; Chimalakonda, A; Hurley, J; Rodrigues, AD; Thorndike, D; Vuppugalla, R; Wagner, A; Yang, Z; Zvyaga, T1
Gonçalves, R; Lopes, J; Macedo, G; Sobrinho Simões, M; Vilas-Boas, F1
Coleman, HM; Khan, SJ; Le-Clech, P; Stuetz, RM; Trinh, T; van den Akker, B1
d'Auriol, M; de Souza Santos, LV; Jacob, RS; Lange, LC; Lebron, YAR; Moreira, VR1

Reviews

6 review(s) available for omeprazole and diazepam

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.
    Digestive diseases and sciences, 1991, Volume: 36, Issue:12

    Topics: Aminopyrine; Animals; Antipyrine; Cytochrome P-450 Enzyme System; Diazepam; Drug Interactions; Humans; Omeprazole; Phenytoin; Propranolol; Theophylline; Warfarin

1991
Lack of pantoprazole drug interactions in man.
    International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin

1994
Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.
    Clinical pharmacokinetics, 1995, Volume: 29, Issue:3

    Topics: Antidepressive Agents; Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Diazepam; Geography; Humans; Mixed Function Oxygenases; Mutation; Omeprazole; Pharmaceutical Preparations; Phenotype; Polymorphism, Genetic; Racial Groups; Substrate Specificity; White People

1995
Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs.
    The American journal of medicine, 2002, Dec-15, Volume: 113, Issue:9

    Topics: Anti-Arrhythmia Agents; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Codeine; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Diazepam; Genotype; Glipizide; Humans; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Phenotype; Phenytoin; Warfarin

2002
Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature.
    Gastroenterologia y hepatologia, 2012, Volume: 35, Issue:8

    Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemical and Drug Induced Liver Injury; Darbepoetin alfa; Diazepam; Erythropoietin; Fatal Outcome; Humans; Jaundice, Obstructive; Liver Function Tests; Male; Melphalan; Multiple Myeloma; Omeprazole; Pneumonia; Polypharmacy; Prednisolone; Thalidomide

2012

Trials

7 trial(s) available for omeprazole and diazepam

ArticleYear
Influence of lansoprazole treatment on diazepam plasma concentrations.
    Clinical pharmacology and therapeutics, 1992, Volume: 52, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Analysis of Variance; Anti-Ulcer Agents; Diazepam; Double-Blind Method; Drug Interactions; Humans; Lansoprazole; Male; Omeprazole; Reference Values

1992
Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole.
    Clinical pharmacology and therapeutics, 1990, Volume: 47, Issue:1

    Topics: Adult; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Humans; Male; Metabolic Clearance Rate; Nordazepam; Omeprazole; Random Allocation

1990
Effect of omeprazole and cimetidine on plasma diazepam levels.
    European journal of clinical pharmacology, 1990, Volume: 39, Issue:1

    Topics: Adult; Cimetidine; Diazepam; Double-Blind Method; Drug Interactions; Half-Life; Humans; Male; Nordazepam; Omeprazole

1990
Interethnic difference in omeprazole's inhibition of diazepam metabolism.
    Clinical pharmacology and therapeutics, 1995, Volume: 58, Issue:1

    Topics: Adult; Asian People; China; Cross-Over Studies; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Debrisoquin; Diazepam; Double-Blind Method; Drug Interactions; Ethnicity; Humans; Male; Mephenytoin; Nordazepam; Omeprazole; Tennessee; White People

1995
Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation.
    Clinical pharmacology and therapeutics, 1995, Volume: 58, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Diazepam; Drug Interactions; Half-Life; Humans; Hydroxylation; Male; Mephenytoin; Mixed Function Oxygenases; Nordazepam; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Reference Values; Single-Blind Method

1995
Lack of pantoprazole drug interactions in man.
    International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin

1994
Lack of pharmacokinetic interaction of pantoprazole with diazepam in man.
    British journal of clinical pharmacology, 1996, Volume: 42, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Anxiety Agents; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Blood Pressure; Cross-Over Studies; Diazepam; Drug Interactions; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Omeprazole; Pantoprazole; Sulfoxides

1996

Other Studies

30 other study(ies) available for omeprazole and diazepam

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
    Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15

    Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water

2001
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Cytochrome P-450 Enzyme Inhibitors; Diazepam; Female; Gastric Acid; H(+)-K(+)-Exchanging ATPase; In Vitro Techniques; Motor Activity; Omeprazole; Pantoprazole; Rabbits; Rats; Rats, Inbred Strains; Sulfoxides

1990
The interaction of omeprazole with rat liver cytochrome P450-mediated monooxygenase reactions in vitro and in vivo.
    Biochemical pharmacology, 1988, Apr-01, Volume: 37, Issue:7

    Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Cimetidine; Diazepam; Ethylmorphine-N-Demethylase; In Vitro Techniques; Male; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Omeprazole; Oxidoreductases; Oxygenases; Rats; Rats, Inbred Strains; Species Specificity

1988
Pharmacokinetics and metabolism of omeprazole in man.
    Scandinavian journal of gastroenterology. Supplement, 1986, Volume: 118

    Topics: Administration, Oral; Aged; Aging; Anti-Ulcer Agents; Benzimidazoles; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Humans; Injections, Intravenous; Kidney Diseases; Kinetics; Omeprazole

1986
Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.
    Gastroenterology, 1985, Volume: 89, Issue:6

    Topics: Adult; Benzimidazoles; Coumarins; Diazepam; Drug Interactions; Humans; In Vitro Techniques; Kinetics; Male; Microsomes, Liver; Nordazepam; Omeprazole; Oxidation-Reduction; Phenytoin

1985
Omeprazole inhibits elimination of diazepam.
    Lancet (London, England), 1984, Apr-28, Volume: 1, Issue:8383

    Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Diazepam; Drug Interactions; Humans; Male; Metabolic Clearance Rate; Omeprazole

1984
Effect of omeprazole on diazepam disposition in the rat: in vitro and in vivo studies.
    Pharmaceutical research, 1995, Volume: 12, Issue:11

    Topics: Animals; Anti-Anxiety Agents; Anti-Ulcer Agents; Biotransformation; Chromatography, High Pressure Liquid; Diazepam; Drug Interactions; In Vitro Techniques; Liver; Male; Microsomes, Liver; Omeprazole; Rats; Rats, Sprague-Dawley; Tissue Distribution

1995
Diazepam-omeprazole inhibition interaction: an in vitro investigation using human liver microsomes.
    British journal of clinical pharmacology, 1996, Volume: 42, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Anti-Ulcer Agents; Diazepam; Drug Interactions; Female; Humans; Ketoconazole; Male; Microsomes, Liver; Middle Aged; Omeprazole

1996
Selectivity of omeprazole inhibition towards rat liver cytochromes P450.
    Xenobiotica; the fate of foreign compounds in biological systems, 1997, Volume: 27, Issue:1

    Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diazepam; Ethylmorphine-N-Demethylase; Ketoconazole; Male; Microsomes, Liver; Omeprazole; Rats; Rats, Sprague-Dawley; Substrate Specificity

1997
Prevalence of potential proton-pump inhibitor drug interactions: a retrospective review of prescriptions in community pharmacies.
    Clinical therapeutics, 1999, Volume: 21, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Diazepam; Drug Interactions; Enzyme Inhibitors; Humans; Lansoprazole; Omeprazole; Pharmacies; Prevalence; Proton Pump Inhibitors; Retrospective Studies; Theophylline; Warfarin

1999
Induction of aneuploidy in male mouse germ cells detected by the sperm-FISH assay: a review of the present data base.
    Mutation research, 2002, Jul-25, Volume: 504, Issue:1-2

    Topics: Acrylamide; Aneuploidy; Animals; Benzimidazoles; Carbamates; Colchicine; Diazepam; Griseofulvin; Humans; In Situ Hybridization, Fluorescence; Male; Meiosis; Mice; Mice, Inbred C3H; Omeprazole; Paclitaxel; Spermatozoa; Substance-Related Disorders; Thiabendazole; Trichlorfon; Vinblastine

2002
Persistent gastroesophageal reflux disease symptoms on standard proton-pump inhibitor therapy.
    Gastroenterology clinics of North America, 2002, Volume: 31, Issue:4 Suppl

    Topics: Adult; Aged; Diazepam; Drug Therapy, Combination; Enzyme Inhibitors; Follow-Up Studies; Gastroesophageal Reflux; Humans; Hypnotics and Sedatives; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome

2002
Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytes.
    Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:5

    Topics: Animals; Binding Sites; Diazepam; Dose-Response Relationship, Drug; Hepatocytes; Kinetics; Male; Metabolic Clearance Rate; Microsomes, Liver; Omeprazole; Predictive Value of Tests; Rats; Rats, Sprague-Dawley

2004
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cells, Cultured; Computer Simulation; Cytochrome P-450 CYP2C19; Dealkylation; Dexlansoprazole; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Hepatocytes; Humans; Kinetics; Lansoprazole; Liver; Microsomes, Liver; Models, Biological; NADP; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Recombinant Proteins; Substrate Specificity

2012
Removal of trace organic chemical contaminants by a membrane bioreactor.
    Water science and technology : a journal of the International Association on Water Pollution Research, 2012, Volume: 66, Issue:9

    Topics: Amitriptyline; Bioreactors; Carbamazepine; Diazepam; Diclofenac; Fluoxetine; Gemfibrozil; Omeprazole; Organic Chemicals; Pharmaceutical Preparations; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Water Pollutants, Chemical

2012
Diazepam, metformin, omeprazole and simvastatin: a full discussion of individual and mixture acute toxicity.
    Ecotoxicology (London, England), 2020, Volume: 29, Issue:7

    Topics: Aliivibrio fischeri; Diazepam; Metformin; Omeprazole; Simvastatin; Toxicity Tests, Acute

2020